Four-Week Therapy With Peginterferon Alfa-2B/Ribavirin Effectively Predicts Sustained Virologic Response in Treatment-NaïVE and Previous-Treatment-Failure Patients With HCV-1 Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin

Previous Treatment ◽

Virologic Response ◽

Treatment Naïve ◽

481 FOUR-WEEK THERAPY WITH PEGINTERFERON ALFA-2B/ RIBAVIRIN EFFECTIVELY PREDICTS SUSTAINED VIROLOGIC RESPONSE IN TREATMENT-NAIVE AND PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV-1 TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN

10.1016/s0168-8278(11)60483-2 ◽

2011 ◽

Vol 54 ◽

pp. S197 ◽

Cited By ~ 4

Author(s):

J.M. Vierling ◽

E.J. Lawitz ◽

F. Poordad ◽

M.S. Sulkowski ◽

M. Bourliere ◽

...

Keyword(s):

Treatment Failure ◽

Previous Treatment ◽

Virologic Response ◽

Treatment Naïve ◽

Adherence to Assigned Dosing Regimen and Sustained Virologic Response Among Hepatitis C Genotype 1 Treatment-NaïVE and PEG/Ribavirin Treatment-Failures Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin

Gastroenterology ◽

10.1016/s0016-5085(11)63913-9 ◽

2011 ◽

Vol 140 (5) ◽

pp. S-944

Author(s):

Stuart C. Gordon ◽

Eric J. Lawitz ◽

Bruce R. Bacon ◽

Mark Sulkowski ◽

Eric M. Yoshida ◽

...

Keyword(s):

Hepatitis C ◽

Virologic Response ◽

Genotype 1 ◽

Dosing Regimen ◽

Treatment Naïve ◽

Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naïve patients with genotype 1, chronic hepatitis C

10.1016/j.jhep.2009.01.017 ◽

2009 ◽

Vol 51 (1) ◽

pp. 21-28 ◽

Cited By ~ 20

Author(s):

Avidan U. Neumann ◽

Stephen Pianko ◽

Stefan Zeuzem ◽

Eric M. Yoshida ◽

Yves Benhamou ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virologic Response ◽

Genotype 1 ◽

Negative Prediction ◽

Treatment Naïve ◽

Telaprevir in Combination with Peginterferon Alfa-2a and Ribavirin Increased Sustained Virologic Response in Genotype 1 Chronic HCV and Allowed for Shorter Treatment Duration in Treatment-naïve and Prior Relapser Patients: 2011 ACG Presidential Poster

The American Journal of Gastroenterology ◽

10.14309/00000434-201110002-00288 ◽

2011 ◽

Vol 106 ◽

pp. S113-S114 ◽

Cited By ~ 2

Author(s):

Gregory Everson ◽

Geoffrey Dusheiko ◽

Stanislas Pol ◽

David Nelson ◽

Andrew Muir ◽

...

Keyword(s):

Treatment Duration ◽

Virologic Response ◽

Genotype 1 ◽

Treatment Naïve ◽

Chronic Hcv ◽

466 PREDICTORS OF SUSTAINED VIROLOGIC RESPONSE AMONG TREATMENT-NAIVE PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 WHEN TREATED WITH BOCEPREVIR (BOC) PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN (PR)

10.1016/s0168-8278(11)60468-6 ◽

2011 ◽

Vol 54 ◽

pp. S190 ◽

Cited By ~ 13

Author(s):

K.R. Reddy ◽

S. Bruno ◽

L. Rossaro ◽

N. Ravendhran ◽

M.P. Pauly ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Virologic Response ◽

Genotype 1 ◽

Virus Genotype ◽

Treatment Naïve ◽

415 TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN INCREASED SUSTAINED VIROLOGIC RESPONSE RATES IN TREATMENT-NAIVE PATIENTS REGARDLESS OF RACE OR ETHNICITY

10.1016/s0168-8278(11)60417-0 ◽

2011 ◽

Vol 54 ◽

pp. S167-S168 ◽

Cited By ~ 3

Author(s):

G.M. Dusheiko ◽

M.W. Fried ◽

R. Reddy ◽

D.R. Nelson ◽

N. Bzowej ◽

...

Keyword(s):

Response Rates ◽

Virologic Response ◽

Treatment Naïve ◽

Predictors of Sustained Virologic Response Among Treatment-NaïVE Patients With Hepatitis C Virus Genotype 1 When Treated With Boceprevir (Boc) Plus Peginterferon Alfa-2B-Ribavirin (PR)

Gastroenterology ◽

10.1016/s0016-5085(11)63910-3 ◽

2011 ◽

Vol 140 (5) ◽

pp. S-943 ◽

Cited By ~ 1

Author(s):

Rajender Reddy ◽

Savino Bruno ◽

Lorenzo Rossaro ◽

Natarajan Ravendhran ◽

Mary Pat Pauly ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Virologic Response ◽

Genotype 1 ◽

Virus Genotype ◽

Treatment Naïve ◽

428 ADHERENCE TO ASSIGNED DOSING REGIMEN AND SUSTAINED VIROLOGIC RESPONSE AMONG HEPATITIS C GENOTYPE 1 TREATMENT-NAIVE AND PEG/RIBAVIRIN TREATMENT-FAILURES TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN

10.1016/s0168-8278(11)60430-3 ◽

2011 ◽

Vol 54 ◽

pp. S173-S174 ◽

Cited By ~ 9

Author(s):

S.C. Gordon ◽

E.J. Lawitz ◽

B.R. Bacon ◽

M.S. Sulkowski ◽

E.M. Yoshida ◽

...

Keyword(s):

Hepatitis C ◽

Virologic Response ◽

Genotype 1 ◽

Dosing Regimen ◽

Treatment Naïve ◽

60 SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION

10.1016/s0168-8278(11)60062-7 ◽

2011 ◽

Vol 54 ◽

pp. S27 ◽

Cited By ~ 23

Author(s):

M.S. Sulkowski ◽

E. Ceasu ◽

T. Asselah ◽

F.A. Caruntu ◽

J. Lalezari ◽

...

Keyword(s):

Virologic Response ◽

Hcv Infection ◽

Genotype 1 ◽

Treatment Naïve ◽

Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin Increased Sustained Virologic Response Rates in Treatment-NaïVE Patients Regardless of Race or Ethnicity

Gastroenterology ◽

10.1016/s0016-5085(11)63769-4 ◽

2011 ◽

Vol 140 (5) ◽

pp. S-908

Author(s):

Steven L. Flamm ◽

Rajender Reddy ◽

Michael W. Fried ◽

Geoffrey M. Dusheiko ◽

David R. Nelson ◽

...

Keyword(s):

Response Rates ◽

Virologic Response ◽

Treatment Naïve ◽